{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:01:26Z","timestamp":1790409686777,"version":"4.1.0"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["2024JBGS04"],"award-info":[{"award-number":["2024JBGS04"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["823B2059"],"award-info":[{"award-number":["823B2059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502914"],"award-info":[{"award-number":["82502914"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20390"],"award-info":[{"award-number":["U21A20390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioactmat.2026.04.031","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:12:09Z","timestamp":1777601529000},"page":"73-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A \u2018three-axis synergy\u2019 immunotherapeutic strategy for malignant bone tumors based on natural bioactives and bioactive materials"],"prefix":"10.1016","volume":"64","author":[{"given":"Xiangjun","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3296-3779","authenticated-orcid":false,"given":"Yanguo","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2026.04.031_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1470-2045(19)30825-3","article-title":"Cabozantinib in patients with advanced ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial","volume":"21","author":"Italiano","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib2","first-page":"20","article-title":"Advancements in research regarding the influence of the tumor microenvironment on the proliferation and metastasis of osteosarcoma (Review)","volume":"31","author":"Shi","year":"2026","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-025-10257-3","article-title":"Microenvironment matters: insights from the FOSTER consortium on microenvironment-driven approaches to osteosarcoma therapy","volume":"44","author":"Dutour","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib4","article-title":"Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4103\/jcrt.jcrt_2269_23","article-title":"New advances in the treatment of chondrosarcoma under the PD-1\/PD-L1 pathway","volume":"20","author":"Yin","year":"2024","journal-title":"J. Cancer Res. Therapeut."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbo.2024.100635","article-title":"The efficacy and applicability of chimeric antigen receptor (CAR) T cell-based regimens for primary bone tumors: a comprehensive review of current evidence","volume":"48","author":"Barzegari","year":"2024","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1394339","article-title":"Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies","volume":"12","author":"Liang","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/REGENMED.REGENMED-D-25-00011","article-title":"Harnessing the immune system and developing targeted vaccines: overall strategies of leveraging the body's natural defense mechanisms to enhance cancer treatment","volume":"2","author":"Banday","year":"2025","journal-title":"Regenerative Medicine Reports"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/REGENMED.REGENMED-D-25-00014","article-title":"How to rejuvenate the prostate damaged by cancer","volume":"2","author":"Liu","year":"2025","journal-title":"Regenerative Medicine Reports"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib10","article-title":"Emerging immunotherapies in osteosarcoma: from checkpoint blockade to cellular therapies","volume":"16","author":"Han","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib11","article-title":"Tumor microenvironment in osteosarcoma: from cellular mechanism to clinical therapy","volume":"12","author":"Yu","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib12","article-title":"Recent advances in biomaterials for osteosarcoma treatment","volume":"13","author":"Han","year":"2025","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-61377-x","article-title":"Sono-activable and biocatalytic 3D-printed scaffolds for intelligently sequential therapies in osteosarcoma eradication and defect regeneration","volume":"16","author":"Rong","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbag031","article-title":"Immunotherapy and postoperative bone defect repair strategies based on osteosarcoma tumor microenvironment characteristics: balancing antitumor effects and promotion of bone regeneration","author":"Guo","year":"2026","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s42114-024-01030-1","article-title":"Metal-based nanocomposites for immunotherapy of osteosarcoma","volume":"7","author":"Hao","year":"2024","journal-title":"Adv. Compos. Hybrid Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib16","first-page":"18","article-title":"Overcoming barriers in primary bone cancer: nanomaterial-enabled immunotherapy","volume":"35","author":"Liu","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib17","doi-asserted-by":"crossref","DOI":"10.34133\/research.0978","article-title":"Dual-function biomaterials for postoperative osteosarcoma: tumor suppression and bone regeneration","volume":"8","author":"Dong","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib18","doi-asserted-by":"crossref","first-page":"12913","DOI":"10.2147\/IJN.S549587","article-title":"Nanotechnology-driven strategies in osteosarcoma advances in treatment: immunotherapy and drug delivery","volume":"20","author":"Su","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210157","article-title":"Recent applications of immunomodulatory biomaterials for disease immunotherapy","volume":"2","author":"Dai","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib20","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.cclet.2021.10.073","article-title":"Natural lotus root-based scaffolds for bone regeneration","volume":"33","author":"Huang","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib21","first-page":"16","article-title":"Time-sequential and multi-functional 3D printed MgO2\/PLGA scaffold developed as a novel biodegradable and bioactive bone substitute for challenging postsurgical osteosarcoma treatment","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2023.112311","article-title":"A \"biomimetic bone-magnet\" with suitable mechanical properties concurrently performs accurate target collection of nanoparticles for magnetothermally driven osteosarcoma thermo-chemotherapy","volume":"234","author":"Liang","year":"2023","journal-title":"Mater. Des."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40824-023-00453-z","article-title":"Application of advanced biomaterials in photothermal therapy for malignant bone tumors","volume":"27","author":"Chao","year":"2023","journal-title":"Biomater. Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib24","first-page":"8","article-title":"Injectable in situ induced robust hydrogel for photothermal therapy and bone fracture repair","volume":"31","author":"Liu","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.msec.2018.12.148","article-title":"Controlled nanoparticle synthesis of Ag\/Fe co-doped hydroxyapatite system for cancer cell treatment","volume":"98","author":"Veerla","year":"2019","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/03946320241308082","article-title":"Curcumin suppresses metastasis, invasion, and proliferation in osteosarcoma cells by regulating the EGFR\/src signaling axis","volume":"38","author":"Liu","year":"2024","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biopha.2021.112257","article-title":"Potential of natural products in osteosarcoma treatment: focus on molecular mechanisms","volume":"144","author":"Tobeiha","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12935-026-04174-w","article-title":"Natural compounds in the treatment of osteosarcoma: just chemotherapy adjuvants? Or is there much more?","volume":"26","author":"Bellavia","year":"2026","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/ten.teb.2024.0002","article-title":"The combination of bioactive herbal compounds with biomaterials for regenerative medicine","volume":"30","author":"Zhou","year":"2024","journal-title":"Tissue Eng., Part B"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1683279","article-title":"Natural bioactive products in the regulation of bone metabolism and regeneration","volume":"16","author":"Ouyang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/lifemedi\/lnae019","article-title":"Regulatory cellular and molecular networks in the bone microenvironment during aging","volume":"3","author":"Zhang","year":"2024","journal-title":"Life Med"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.34133\/research.0089","article-title":"Smart hydrogels for bone reconstruction via modulating the microenvironment","volume":"6","author":"Chen","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13046-021-02035-0","article-title":"Cellular senescence or stemness: hypoxia flips the coin","volume":"40","author":"Otero-Albiol","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib34","first-page":"19","article-title":"3D-Printed titanium trabecular scaffolds with sustained release of hypoxia-induced exosomes for dual-mimetic bone regeneration","volume":"12","author":"Luo","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib35","article-title":"SIRT5 promotes the osteo-inductive potential of BMP9 by stabilizing the HIF-1\u03b1 protein in mouse embryonic fibroblasts","volume":"12","author":"Liu","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41574-025-01162-4","article-title":"The role of bone in whole-body energy metabolism","volume":"21","author":"Lecka-Czernik","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/09603271241269028","article-title":"The autocrine action of salidroside on osteoclast during osteoclastogenesis via hypoxia-inducible factor-1\u03b1 pathway","volume":"43","author":"Jin","year":"2024","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib38","first-page":"22","article-title":"Versatile hypoxic extracellular vesicles laden in an injectable and bioactive hydrogel for accelerated bone regeneration","volume":"33","author":"Deng","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib39","first-page":"29","article-title":"The role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity","volume":"9","author":"Xiong","year":"2022","journal-title":"Milit. Med. Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jbmr.4773","article-title":"Macrophages and bone remodeling","volume":"38","author":"Weivoda","year":"2023","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-025-02326-4","article-title":"Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib42","article-title":"Recent progress in immunomodulation-based strategies for bone repair","volume":"31","author":"Yuqiang","year":"2026","journal-title":"Regen. Ther."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib43","first-page":"15","article-title":"The horizon of bone organoid: a perspective on construction and application","volume":"18","author":"Chen","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib44","first-page":"4110","article-title":"Bone physiological microenvironment and healing mechanism: basis for future bone-tissue engineering scaffolds","volume":"6","author":"Zhu","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/jfb16060217","article-title":"Applications of osteoimmunomodulation models in evaluating osteogenic biomaterials","volume":"16","author":"Wang","year":"2025","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311642","article-title":"Immune-guided bone healing: the role of osteoimmunity in tissue engineering approaches","volume":"26","author":"Munao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib47","article-title":"Immune regulation enhances osteogenesis and angiogenesis using an injectable thiolated hyaluronic acid hydrogel with lithium-doped nano-hydroxyapatite (Li-nHA) delivery for osteonecrosis","volume":"25","author":"Luo","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib48","article-title":"Osteoimmunology uncovered: how macrophages and biomaterials revolutionize bone healing","volume":"36","author":"Wang","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib49","article-title":"Immunometabolism of macrophages in the bone microenvironment: a new perspective for bone healing therapy","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib50","article-title":"The bone microenvironment: new insights into the role of stem cells and cell communication in bone regeneration","volume":"16","author":"Carbonare","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00441-023-03743-z","article-title":"Immune microenvironment: novel perspectives on bone regeneration disorder in osteoradionecrosis of the jaws","volume":"392","author":"Chen","year":"2023","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib52","article-title":"Research progress on biomaterials with immunomodulatory effects in bone regeneration","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbaf006","article-title":"Spatiotemporal regulation of the bone immune microenvironment via a 'Zn2+-quercetin' hierarchical delivery system for bone regeneration","volume":"12","author":"Sun","year":"2025","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib54","article-title":"Modulating immune-stem cell crosstalk enables robust bone regeneration via tuning compositions of macroporous scaffolds","volume":"10","author":"Su","year":"2025","journal-title":"npj Regener. Med."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib55","article-title":"The cellular-centered view of hypoxia tumor microenvironment: molecular mechanisms and therapeutic interventions","volume":"1879","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib56","article-title":"Hypoxia inducible factor-1\u03b1 as a potential therapeutic target for osteosarcoma metastasis","volume":"15","author":"Zhou","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib57","article-title":"On the importance of acidity in cancer cells and therapy","volume":"13","author":"Tafech","year":"2024","journal-title":"Biology-Basel"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib58","article-title":"Carbonic anhydrase IX: an atypical target for innovative therapies in cancer","volume":"1879","author":"Ronca","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cells14100693","article-title":"Cooperative role of carbonic anhydrase IX\/XII in driving tumor invasion and metastasis: a novel targeted therapeutic strategy","volume":"14","author":"Yang","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350511","article-title":"Acidity promotes the differentiation of immunosuppressive regulatory T cells","volume":"53","author":"Tuomela","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1175563","article-title":"Association between pH regulation of the tumor microenvironment and immunological state","volume":"13","author":"Hosonuma","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221924","article-title":"Emerging role of extracellular pH in tumor microenvironment as a therapeutic target for cancer immunotherapy","volume":"13","author":"Rahman","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14010094","article-title":"Hypoxia-induced reactive oxygen species: their role in cancer resistance and emerging therapies to overcome it","volume":"14","author":"Mendoza","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib64","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1002\/1878-0261.70151","article-title":"A guide to reactive oxygen species in tumour hypoxia: measurement and therapeutic implications","volume":"19","author":"Hacker","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02375-x","article-title":"Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers","volume":"24","author":"Liang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1498060","article-title":"Immunotherapy of osteosarcoma based on immune microenvironment modulation","volume":"15","author":"Lian","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib68","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1007\/s00262-021-02876-w","article-title":"Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial","volume":"70","author":"Boye","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1600792","article-title":"Galectin-9 and Tim-3 in gastric cancer: a checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade","volume":"16","author":"Hill","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib70","article-title":"Decoding the immune microenvironment in osteosarcoma: new insights into checkpoints, vaccines, and CAR-T cells","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib71","article-title":"B7-H3 in the tumor microenvironment: implications for CAR T cell therapy in pediatric solid tumors","volume":"vol. 44","author":"Jansen","year":"2025"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib72","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-024-03642-4","article-title":"Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity","volume":"73","author":"Cao","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13045-022-01364-7","article-title":"Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy","volume":"15","author":"Zhao","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-10229-8","article-title":"B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both In vitro and in vivo","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221862","article-title":"CD47 in osteosarcoma: correlation with metastasis and macrophage-mediated phagocytosis","volume":"13","author":"Ko","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216412","article-title":"SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake","volume":"576","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081930","article-title":"CD47-SIRP\u03b1 checkpoint disruption in metastases requires tumor-targeting antibody for molecular and engineered macrophage therapies","volume":"14","author":"Andrechak","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.32604\/or.2023.042383","article-title":"Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy","volume":"32","author":"Chen","year":"2024","journal-title":"Oncology Research"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib79","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.32604\/or.2025.071708","article-title":"CD47-Targeted therapy in cancer immunotherapy: at a crossroads of promise and challenge","volume":"33","author":"Guo","year":"2025","journal-title":"Oncology Research"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2025.104982","article-title":"Revisiting TAM polarization: beyond M1-and M2-type TAM toward clinical precision in macrophage-targeted therapy","volume":"143","author":"Wang","year":"2025","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295684","article-title":"Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs","volume":"14","author":"Shao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.911368","article-title":"Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma","volume":"14","author":"Tu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib83","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05002-3","article-title":"Diffuse large B-cell lymphoma: the significance of CD8+ tumor-infiltrating lymphocytes exhaustion mediated by TIM3\/Galectin-9 pathway","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107417","article-title":"Deciphering the heterogeneity and immunosuppressive function of regulatory T cells in osteosarcoma using single-cell RNA transcriptome","volume":"165","author":"Cheng","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fcell.2022.886305","article-title":"The osteoclast traces the route to bone tumors and metastases","volume":"10","author":"Russo","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib86","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2147\/CMAR.S431213","article-title":"Osteoclasts in osteosarcoma: mechanisms, interactions, and therapeutic prospects","volume":"15","author":"Gao","year":"2023","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fcell.2022.974851","article-title":"Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117466","article-title":"Extracellular pH is a critical regulator of osteoclast fusion, size and activation","volume":"195","author":"Davies","year":"2025","journal-title":"Bone"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib89","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/bst.2021.01357","article-title":"Effects and mechanisms of microenvironmental acidosis on osteoclast biology","volume":"16","author":"Gong","year":"2022","journal-title":"Biosci Trends"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib90","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/jbmr.4615","article-title":"Bone microenvironment\u2010suppressed T cells increase osteoclast formation and osteolytic bone metastases in mice","volume":"37","author":"Arellano","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116675","article-title":"Effect of T cells on bone","volume":"168","author":"Okamoto","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100505","article-title":"Immune checkpoint inhibitors in bone metastasis: clinical challenges, toxicities, and mechanisms","volume":"43","author":"Joseph","year":"2023","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.105076","article-title":"Harnessing the effector-to-regulatory T cell ratio to advance prognosis and precision therapy in pancreatic cancer","volume":"218","author":"Guo","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2024.100604","article-title":"Single-cell transcriptional profiling in osteosarcoma and the effect of neoadjuvant chemotherapy on the tumor microenvironment","volume":"46","author":"He","year":"2024","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib95","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10528-023-10483-w","article-title":"Single-cell RNA sequencing pro-angiogenic macrophage profiles reveal novel prognostic biomarkers and therapeutic targets for osteosarcoma","volume":"62","author":"Yi","year":"2024","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.911368","article-title":"Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma","volume":"14","author":"Tu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib97","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41413-023-00246-z","article-title":"Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment","volume":"11","author":"Tian","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib98","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib99","article-title":"Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jitc-2024-009472","article-title":"A multicenter, randomized, non-comparative, phase II study of nivolumab \u00b1 ipilimumab for patients with metastatic sarcoma (alliance A091401): expansion cohorts and correlative analyses","volume":"12","author":"Seligson","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1539696","article-title":"New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma","volume":"15","author":"Luo","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106287","article-title":"Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 Via the JAK2-STAT3-PDL1","volume":"182","author":"Jing","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib103","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41577-025-01221-x","article-title":"Regulators of CD8+ T cell exhaustion","volume":"26","author":"Sun","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib104","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.trecan.2022.04.004","article-title":"Mechanisms of T cell exhaustion guiding next-generation immunotherapy","volume":"8","author":"Zebley","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib105","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib106","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.apsb.2020.06.014","article-title":"Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib107","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib108","article-title":"Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib109","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8048170","article-title":"Triptolide inhibits osteoclast differentiation and bone resorption in vitro via enhancing the production of IL-10 and TGF-\u03b21 by regulatory T cells","volume":"2016","author":"Xu","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1516609","article-title":"Resveratrol-driven macrophage polarization: unveiling mechanisms and therapeutic potential","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib111","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ccell.2024.04.002","article-title":"A temporal perspective for tumor-associated macrophage identities and functions","volume":"42","author":"Bl\u00e9riot","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114370","article-title":"Development of natural products for anti-PD-1\/PD-L1 immunotherapy against cancer","volume":"281","author":"Ri","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib113","article-title":"Tumor microenvironment in osteosarcoma: from cellular mechanism to clinical therapy","volume":"12","author":"Yu","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.amjms.2025.09.014","article-title":"Osteoimmunology: the little niche with the big impact","volume":"371","author":"Yadav","year":"2026","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010753","article-title":"RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells","volume":"13","author":"Pilard","year":"2025","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib116","article-title":"Roles of the RANKL\u2013RANK axis in Immunity\u2014implications for pathogenesis and treatment of bone metastasis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib117","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1152\/physiol.00020.2022","article-title":"RANKL and RANK in cancer therapy","volume":"38","author":"Onji","year":"2023","journal-title":"Physiology"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib118","article-title":"Research progress on the regulatory effect of curcumin on mesenchymal stem cells","volume":"27","author":"Sun","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2023.100605","article-title":"Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway","volume":"47","author":"Ke","year":"2024","journal-title":"Biomed. J."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib120","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.3390\/cancers17152491","article-title":"From spice to survival: the emerging role of curcumin in cancer immunotherapy","volume":"17","author":"Parker","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155898","article-title":"Curcumin enhances anti-tumor immunity in anaplastic thyroid carcinoma by elevating CD8+ T cell function and downregulating the AKT\/mTORC1\/STAT3\/PD-L1 axis","volume":"269","author":"Zheng","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib122","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib123","article-title":"CD8+ T\u00a0cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy","volume":"4","author":"Huseni","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib124","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/intimm\/dxr077","article-title":"IL-1\u03b2 and TNF\u03b1-initiated IL-6\u2013STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis","volume":"23","author":"Mori","year":"2011","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib125","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.3390\/ijms26178707","article-title":"Coptidis rhizoma water extract attenuates RANKL-induced osteoclast differentiation via MAPK, Akt, and NF-\u03baB pathways and prevents ovariectomy (OVX)-mediated bone loss","volume":"26","author":"Han","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116523","article-title":"Mitigation of inflammatory bowel disease-related osteoporosis by oxyberberine: insights into the RANKL\/NF-\u03baB signaling pathway","volume":"174","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib127","article-title":"Tumor microenvironment in osteosarcoma: from cellular mechanism to clinical therapy","volume":"12","author":"Yu","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114646","article-title":"The impact of hypoxia on tumor-mediated bypassing anti-PD-(L)1 therapy","volume":"162","author":"Mortezaee","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib129","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.tibs.2025.06.005","article-title":"The HIF axes in cancer: angiogenesis, metabolism, and immune-modulation","volume":"50","author":"Acu\u00f1a-Pilarte","year":"2025","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib130","article-title":"Hypoxia inducible factor-1\u0251 as a potential therapeutic target for osteosarcoma metastasis","volume":"15","author":"Zhou","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib131","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jcb.21851","article-title":"Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis","volume":"105","author":"Lee","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib132","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1476-4598-9-268","article-title":"Increased accumulation of hypoxia-inducible factor-1\u03b1 with reduced transcriptional activity mediates the antitumor effect of triptolide","volume":"9","author":"Zhou","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101536","article-title":"A glucose-triptolide conjugate selectively targets cancer cells under hypoxia","volume":"23","author":"Datan","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1563303","article-title":"Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives","volume":"16","author":"Gu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib136","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molimm.2024.08.004","article-title":"Acidity induces durable enhancement of Treg cell suppressive functions for tumor immune evasion","volume":"174","author":"Mani","year":"2024","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib137","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1038\/s44318-024-00235-w","article-title":"Acidity suppresses CD8 + T-cell function by perturbing IL-2, mTORC1, and c-Myc signaling","volume":"43","author":"Vuillefroy de Silly","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/nu18010053","article-title":"Curcumin rewires the tumor metabolic landscape: mechanisms and clinical prospects","volume":"18","author":"Sun","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib139","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s43018-024-00738-9","article-title":"The pleiotropic functions of reactive oxygen species in cancer","volume":"5","author":"Wu","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib140","article-title":"Reactive oxygen species of tumor microenvironment: harnessing for immunogenic cell death","volume":"1879","author":"Malla","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1734653","article-title":"Curcumin enhances GSDME-mediated pyroptosis to potentiate PD-1\/PD-L1 immune checkpoint blockade in colorectal cancer","volume":"17","author":"Tan","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib142","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-20179-6","article-title":"Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth","volume":"8","author":"Larasati","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib143","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/ph17020164","article-title":"Bioavailability of oral curcumin in systematic reviews: a methodological study","volume":"17","author":"Bu\u010devi\u0107 Popovi\u0107","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib144","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1021\/acsomega.2c07326","article-title":"Curcumin formulations for better bioavailability: what we learned from clinical trials thus far?","volume":"8","author":"Hegde","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2024.140262","article-title":"The bioavailability, absorption, metabolism, and regulation of glucolipid metabolism disorders by quercetin and its important glycosides: a review","volume":"458","author":"Zhu","year":"2024","journal-title":"Food Chem."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib146","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1021\/acs.cgd.3c00590","article-title":"Tuning the pharmacokinetic performance of quercetin by cocrystallization","volume":"23","author":"Haskins","year":"2023","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib147","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3390\/ph16111631","article-title":"Quercetin as a therapeutic product: evaluation of its pharmacological action and clinical applications\u2014A review","volume":"16","author":"Mirza","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib148","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib149","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwac206","article-title":"Natural products and drug discovery","volume":"9","author":"Newman","year":"2022","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22098","article-title":"A strategy for quality evaluation of complex herbal preparations based on multi-color scale and efficacy-oriented high-performance thin-layer chromatography characteristic fingerprint combined with chemometric method: Sanwujiao pills as an example","volume":"9","author":"Pei","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib151","article-title":"Advancing herbal medicine: enhancing product quality and safety through robust quality control practices","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110651","article-title":"Recent advances in the pharmacological applications and liver toxicity of triptolide","volume":"382","author":"Cui","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib153","article-title":"Insights into the mechanisms of triptolide nephrotoxicity through network pharmacology-based analysis and RNA-seq","volume":"14","author":"Luo","year":"2023","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib154","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10565-024-09930-0","article-title":"Triptolide induces hepatotoxicity by promoting ferroptosis through Nrf2 degradation","volume":"40","author":"Guo","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122714","article-title":"Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment","volume":"312","author":"Chu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1042625","article-title":"Recent advances in hydrogels-based osteosarcoma therapy","volume":"10","author":"Tian","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib157","article-title":"Recent advances in biomaterials for Osteosarcoma treatment","volume":"13","author":"Han","year":"2025","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib158","doi-asserted-by":"crossref","first-page":"978","DOI":"10.34133\/research.0978","article-title":"Dual-function biomaterials for postoperative osteosarcoma: tumor suppression and bone regeneration","volume":"8","author":"Dong","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib159","doi-asserted-by":"crossref","DOI":"10.1038\/s43246-024-00612-2","article-title":"Recent advances in drug delivery systems for osteosarcoma therapy and bone regeneration","volume":"5","author":"Kortam","year":"2024","journal-title":"Commun. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1640560","article-title":"Physical cues in biomaterials modulate macrophage polarization for bone regeneration: a review","volume":"13","author":"Yang","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.150631","article-title":"Macrophage-mediated immunomodulation in biomaterial-assisted bone repair: molecular insights and therapeutic prospects","volume":"488","author":"Bi","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib162","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1039\/D5BM00357A","article-title":"Osteoimmunomodulation by bone implant materials: harnessing physicochemical properties and chemical composition","volume":"13","author":"Sanati","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib163","first-page":"810","article-title":"Calcium silicate bioactive ceramics induce osteogenesis through oncostatin M","volume":"6","author":"Zhou","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122992","article-title":"A biodegradable magnesium alloy promotes subperiosteal osteogenesis via interleukin-10-dependent macrophage immunomodulation","volume":"318","author":"Chen","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23005-2","article-title":"TRPM7 kinase-mediated immunomodulation in macrophage plays a central role in magnesium ion-induced bone regeneration","volume":"12","author":"Qiao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122959","article-title":"Injectable and adhesive MgO2-potentiated hydrogel with sequential tumor synergistic therapy and osteogenesis for challenging postsurgical osteosarcoma treatment","volume":"315","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.153346","article-title":"Immune amplifying hydrogel microspheres with STING activation improve tumor retention for photoimmunotherapy","volume":"496","author":"Luo","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib168","article-title":"Make it STING: nanotechnological approaches for activating cGAS\/STING as an immunomodulatory node in osteosarcoma","volume":"15","author":"O'Donoghue","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib169","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12951-025-03253-w","article-title":"Biopolymer-based bone scaffold for controlled Pt (IV) prodrug release and synergistic photothermal-chemotherapy and immunotherapy in osteosarcoma","volume":"23","author":"Yan","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib170","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20230117","article-title":"Cascade loop of ferroptosis induction and immunotherapy based on metal-phenolic networks for combined therapy of colorectal cancer","volume":"5","author":"Li","year":"2025","journal-title":"Exploration"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib171","doi-asserted-by":"crossref","first-page":"33","DOI":"10.22203\/eCM.v050a03","article-title":"Innovative immunomodulatory strategies in the management of peri-implantitis: current paradigms and future directions","volume":"50","author":"Wang","year":"2025","journal-title":"Eur. Cell. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib172","article-title":"Traditional Chinese medicine compound-loaded materials in bone regeneration","volume":"10","author":"Shi","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib173","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40820-024-01557-4","article-title":"Recent strategies and advances in hydrogel-based delivery platforms for bone regeneration","volume":"17","author":"Wang","year":"2024","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib174","article-title":"Exploring the frontiers: the potential and challenges of bioactive scaffolds in osteosarcoma treatment and bone regeneration","volume":"29","author":"Zhang","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib175","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/antiox10040616","article-title":"Curcumin-loaded hydrophobic surface-modified hydroxyapatite as an antioxidant for sarcopenia prevention","volume":"10","author":"Liang","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib176","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbab022","article-title":"Repair calvarial defect of osteoporotic rats by berberine functionalized porous calcium phosphate scaffold","volume":"8","author":"Wang","year":"2021","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib177","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1039\/D2TB02547G","article-title":"In Vivo and in vitro properties evaluation of curcumin loaded MgO doped 3D printed TCP scaffolds","volume":"11","author":"Bhattacharjee","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib178","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbab044","article-title":"Gelatin methacrylate hydrogel scaffold carrying resveratrol-loaded solid lipid nanoparticles for enhancement of osteogenic differentiation of BMSCs and effective bone regeneration","volume":"8","author":"Wei","year":"2021","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib179","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12951-024-02352-4","article-title":"Quercetin-loaded mesoporous nano-delivery system remodels osteoimmune microenvironment to regenerate alveolar bone in periodontitis via the miR-21a-5p\/PDCD4\/NF-\u03baB pathway","volume":"22","author":"Yang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib180","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s40883-025-00439-4","article-title":"Multiple drug delivery ability of calcium phosphate scaffolds promotes osteogenic gene expression in in vitro Co-culture model","volume":"12","author":"Sarkar","year":"2025","journal-title":"Regener. Eng. Transl. Med."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2024.101292","article-title":"Progress in nanomaterial-based synergistic photothermal-enhanced chemodynamic therapy in combating bacterial infections","volume":"144","author":"Manivasagan","year":"2024","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib182","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1039\/D5NP00008D","article-title":"Progress on targeted discovery of microbial natural products based on the predictions of both structure and activity","volume":"42","author":"Zhang","year":"2025","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib183","first-page":"23","article-title":"Tumor-targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib184","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/adfm.202307013","article-title":"Alendronate triggered dual-cascade targeting prodrug nanoparticles for enhanced tumor penetration and STING activation of osteosarcoma","volume":"33","author":"Shen","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/adma.202404971","article-title":"Glutathione-scavenging Celastrol-Cu nanoparticles induce self-amplified cuproptosis for augmented cancer immunotherapy","volume":"36","author":"Lu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib186","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biomaterials.2023.122236","article-title":"Multifunctional 3D-printed scaffolds eradiate orthotopic osteosarcoma and promote osteogenesis via microwave thermo-chemotherapy combined with immunotherapy","volume":"301","author":"Ma","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib187","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biomaterials.2022.121407","article-title":"Enhancement of anti-PD-1\/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework","volume":"282","author":"Ge","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib188","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2147\/IJN.S503248","article-title":"Acid-unlocked two-layer Ca-Loaded nanoplatform to interfere with mitochondria for synergistic tumor therapy","volume":"20","author":"Zheng","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib189","doi-asserted-by":"crossref","first-page":"19932","DOI":"10.1016\/j.ceramint.2023.03.115","article-title":"Nanostructured system based on hydroxyapatite and curcumin: a promising candidate for osteosarcoma therapy","volume":"49","author":"Marinho","year":"2023","journal-title":"Ceram. Int."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib190","first-page":"396","article-title":"Chemical bonding of Epigallocatechin-3-gallate to the surface of nano-hydroxyapatite to enhance its biological activity for anti-osteosarcoma","volume":"4","author":"Ren","year":"2023","journal-title":"Smart Mater. Med."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib191","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1007\/s40843-024-3139-3","article-title":"Tannic acid-based metal-phenolic networks as a versatile platform to mediate cell therapy","volume":"67","author":"Luo","year":"2024","journal-title":"Sci. China Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib192","article-title":"Metal-phenolic network biointerface-mediated cell regulation for bone tissue regeneration","volume":"30","author":"Wang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib193","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.actbio.2023.08.046","article-title":"Aspect ratio-dependent dual-regulation of the tumor immune microenvironment against osteosarcoma by hydroxyapatite nanoparticles","volume":"170","author":"Wu","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib194","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1039\/D3BM02054A","article-title":"Intranuclear assembly of leucine-rich peptides for selective death of osteosarcoma cells","volume":"12","author":"Liu","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fbioe.2023.1268049","article-title":"Extrusion-based 3D printing of osteoinductive scaffolds with a spongiosa-inspired structure","volume":"11","author":"K\u00fchl","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib196","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib197","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1039\/D4NR00284A","article-title":"Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy","volume":"16","author":"Zhong","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib198","first-page":"221","article-title":"Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma","volume":"17","author":"Fu","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib199","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1039\/D0BM02048F","article-title":"Engineering calcium peroxide based oxygen generating scaffolds for tissue survival","volume":"9","author":"Suvarnapathaki","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib200","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13726-023-01147-y","article-title":"Effect of calcium peroxide particles as oxygen-releasing materials on cell growth and mechanical properties of scaffolds for tissue engineering","volume":"32","author":"Mollajavadi","year":"2023","journal-title":"Iran. Polym. J."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib201","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.3390\/ma18112568","article-title":"Preparation and properties of calcium peroxide\/poly(ethylene glycol)@Silica nanoparticles with controlled oxygen-generating behaviors","volume":"18","author":"Xie","year":"2025","journal-title":"Materials"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.115369","article-title":"Multifunctional scaffold integrating chemo\/photothermal therapy and bone defect reconstruction for osteosarcoma: an in vitro evaluation","volume":"259","author":"Jin","year":"2026","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib203","doi-asserted-by":"crossref","first-page":"46362","DOI":"10.1021\/acsomega.3c06944","article-title":"Advances in the application of photothermal composite scaffolds for osteosarcoma ablation and bone regeneration","volume":"8","author":"Chen","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib204","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202100962","article-title":"Wireless localized electrical stimulation generated by an ultrasound-driven piezoelectric discharge regulates proinflammatory macrophage polarization","volume":"8","author":"Kong","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib205","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-23364-6","article-title":"Barium titanate piezoelectric nanoparticles induce M1 polarization in mouse macrophages via ultrasound in vitro","volume":"15","author":"Connolly","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.116035","article-title":"Ultrasound-activated piezoelectric BZT nanocubes mediate direct piezocatalytic killing and reverse immunosuppressive tumor microenvironment for effective hepatocellular carcinoma therapy","volume":"169","author":"Wang","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib207","first-page":"15","article-title":"An \"Outer Piezoelectric and Inner Epigenetic\" logic-gated PANoptosis for osteosarcoma sono-immunotherapy and bone regeneration","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib208","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijbiomac.2024.132029","article-title":"Cu-Tremella fuciformis polysaccharide-based tumor microenvironment-responsive injectable gels for cuproptosis-based synergistic osteosarcoma therapy","volume":"270","author":"Xie","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib209","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.actbio.2024.12.049","article-title":"Assembly of a biomimetic copper-based nanocomplex for alleviating hypoxia to enhance cuproptosis against osteosarcoma and lung metastasis","volume":"193","author":"Wu","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib210","doi-asserted-by":"crossref","first-page":"22722","DOI":"10.1039\/D2RA03786F","article-title":"Application of nanosonosensitizer materials in cancer sono-dynamic therapy","volume":"12","author":"Hu","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib211","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1039\/D3NA00738C","article-title":"Nanotechnology-enabled sonodynamic therapy against malignant tumors","volume":"6","author":"Huang","year":"2024","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115696","article-title":"Sonodynamic therapy: transforming sound into light for hard-to-treat tumours","volume":"226","author":"Cressey","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib213","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwaf365","article-title":"Sonodynamic therapy augmented by glycolysis inhibition: a novel metabolic reprogramming strategy for enhanced osteosarcoma treatment","volume":"12","author":"Song","year":"2025","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib214","first-page":"4935","article-title":"A naturally-inspired, curcumin-based lecithin formulation (Meriva\u00ae formulated as the finished product algocur\u00ae) alleviates the osteo-muscular pain conditions in rugby players","volume":"21","author":"Di Pierro","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib215","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/JCP.0000000000000508","article-title":"Safety, tolerance, and enhanced efficacy of a bioavailable formulation of curcumin with fenugreek dietary fiber on occupational stress: a randomized, double-blind, placebo-controlled pilot study","volume":"36","author":"Pandaran Sudheeran","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib216","article-title":"Use of ginger to control nausea and vomiting caused by chemotherapy in patients with cervical cancer undergoing treatment: an experiment","volume":"101","author":"da Silva","year":"2022","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib217","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.7150\/thno.81650","article-title":"Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccination","volume":"13","author":"Feng","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib218","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41570-025-00705-7","article-title":"Supramolecular approaches for the treatment of hypoxic regions in tumours","volume":"9","author":"Regeni","year":"2025","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.bioactmat.2026.04.031_bib219","first-page":"221","article-title":"Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma","volume":"17","author":"Fu","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2022.106287","article-title":"Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 via the JAK2-STAT3-PDL1","volume":"182","author":"Jing","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioactmat.2026.04.031_bib221","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2147\/IJN.S398046","article-title":"Resveratrol loaded by folate-modified liposomes inhibits osteosarcoma growth and lung metastasis via regulating JAK2\/STAT3 pathway","volume":"18","author":"Zhu","year":"2023","journal-title":"Int. J. Nanomed."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:42:50Z","timestamp":1790408570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":221,"alternative-id":["S2452199X26002331"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.04.031","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A \u2018three-axis synergy\u2019 immunotherapeutic strategy for malignant bone tumors based on natural bioactives and bioactive materials","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}